Hamada, M., Bhakta, V., Andres, S. N., & Sheffield, W. P. (2021). Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant. Front Cardiovasc Med.
Chicago Style CitationHamada, Mostafa, Varsha Bhakta, Sara N. Andres, i William P. Sheffield. "Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa As Active As the M358R Variant." Front Cardiovasc Med 2021.
Cita MLAHamada, Mostafa, Varsha Bhakta, Sara N. Andres, i William P. Sheffield. "Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa As Active As the M358R Variant." Front Cardiovasc Med 2021.